The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation
Open accessAbstract
Objective: To propose a new decision algorithm combining biomarkers measured in a tumor biopsy with clinical variables, to predict recurrence after liver transplantation (LT). Background: Liver cancer is one of the most frequent causes of cancer-related mortality. LT is the best treatment for hepatocellular carcinoma (HCC) patients but the scarcity of organs makes patient selection a critical step. In addition, clinical criteria widely applied in patient eligibility decisions miss potentially curable patients while selecting patients that relapse after transplantation. Methods: A literature systematic review singled out candidate biomarkers whose RNA levels were assessed by quantitative PCR in tumor tissue from 138 HCC patients submitted to LT (>5 years follow up, 32% beyond Milan criteria). The resulting 4 gene signature was combined with clinical variables to develop a decision algorithm using machine learning approaches. The method was named HepatoPredict. Results: HepatoPredict identifies 99% disease-free patients (>5 year) from a retrospective cohort, including many outside clinical criteria (16%–24%), thus reducing the false negative rate. This increased sensitivity is accompanied by an increased positive predictive value (88.5%–94.4%) without any loss of long-term overall survival or recurrence rates for patients deemed eligible by HepatoPredict; those deemed ineligible display marked reduction of survival and increased recurrence in the short and long term. Conclusions: HepatoPredict outperforms conventional clinical-pathologic selection criteria (Milan, UCSF), providing superior prognostic information. Accurately identifying which patients most likely benefit from LT enables an objective stratification of waiting lists and information-based allocation of optimal versus suboptimal organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, another work utilised the ML-based HepatoPredict61 tool, which combines gene expression signatures with clinical variables, to support post-LT stratification of patients with HCC.62 This study demonstrated that the algorithm, initially developed for patient selection for LT, could also be used to predict post-LT recurrence using the same biomarkers combined with features obtained from”
From Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024 (2024) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D. Y., Camargo, A., Gupta, S., Moore, J., Wrobel, M. J., Lerner, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804525 · Cited by 1,286
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, J. M., De Baere, T., Kulik, L., Haber, P. K., Greten, T. F., Meyer, T., & Lencioni, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00395-0 · Cited by 1,044
Clavien, P.-A., Lesurtel, M., Bossuyt, P. M., Gores, G. J., Langer, B., & Perrier, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70175-9 · Cited by 1,026
Duvoux, C., Roudot–Thoraval, F., Decaens, T., Pessione, F., Badran, H., Piardi, T., Francoz, C., Compagnon, P., Vanlemmens, C., Dumortier, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.052 · Cited by 955
Research works printed but not linked: 1
- Carr, 2018, HCC with low- and normal-serum alpha-fetoprotein levels, Clin Pract (Lond), 15, 453
Cited by
Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024
Žigutytė, L., Sorz-Nechay, T., Clusmann, J., & Kather, J. N. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101209 · Cited by 33
Use of machine learning models for the prognostication of liver transplantation: A systematic review
Chongo, G., & Soldera, J. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i1.88891 · Cited by 37
Berenguer, M., Martin, E. D., Hessheimer, A. J., Levitsky, J., Maluf, D. G., Mas, V. R., Selzner, N., Hernández‐Évole, H., Lutu, A., Wahid, N. A., et al. (2023) · Transplant International · doi:10.3389/ti.2023.11358 · Cited by 19
“powered studies that definitively establish their ability to accurately predict post-LT HCC recurrence and/or survival [41, 42].”
BackgroundLing, S., Yu, J.-J., Zhan, Q., Gao, M., Liu, P., Wu, Y., Zhang, L., Shan, Q., Liu, H., Wang, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59745-8 · Cited by 16
Turning the Tide—Artificial Intelligence in the Evolving Landscape of Liver Cancer
Grapa, C. M., Mocan, T., Mocan, L. P., Motofelea, A., Stănciulescu, R., Crăciun, R., Vârciu, A., Sparchez, Z. A., & Mocan, T. (2025) · Cancers · doi:10.3390/cancers17183003 · Cited by 10
“This suggests that AI models could refine transplant eligibility beyond morphological criteria, improving allocation in settings of organ scarcity [87].”
Metadata
- Authors
- Pinto-Marques, H., Cardoso, J., Silva, S., Neto, J. L., Gonçalves-Reis, M., Proença, D., Mesquita, M., Manso, A., Carapeta, S., Sobral, M., Figueiredo, A., Rodrigues, C., Milheiro, A., Carvalho, A., Perdigoto, R., Barroso, E., & Pereira-Leal, J. B.
- Affiliations
- Hepato-Biliary-Pancreatic and Transplantation Centre, Curry Cabral Hospital, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
- Ophiomics—Precision Medicine, Lisbon, Portugal
- Unidade Local de Saúde de São José (PT)
- Instituto Gulbenkian de Ciência (PT)
- Corresponding author
- Silva, Sílvia
- Sobral, Mafalda
- Rodrigues, Clara
- Milheiro, Adelaide
- Carvalho, Ana
- Perdigoto, Rui
- Barroso, Eduardo
- ORCID
- Venue
- Annals of Surgery
- Published
- 2022-08-01
- Volume
- 276
- Issue
- 5
- Pages
- 868-874
- ISSN
- 0003-4932 (ISSN-L)
- PMC
- PMC9534058
- OpenAlex
- W4289525814
- Cited by
- 20
- References
- 62
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 5 · 2023: 3
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Annals of Surgery (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- HORIZON EUROPE European Innovation Council (946364)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- hepatocellular carcinoma, liver transplantation, patient selection, gene expression signatures, tumor recurrence prediction, biomarkers, decision-making algorithm, Milan criteria, UCSF criteria, organ allocation, prognostic model
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Neoplasm Recurrence, Local, Retrospective Studies, Risk Factors, RNA, Liver Transplantation, Patient Selection, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. https://app.cochat.ai/papers/10.1097/sla.0000000000005637
- The paper
- Pinto-Marques, H., Cardoso, J., Silva, S., Neto, J. L., Gonçalves-Reis, M., Proença, D., Mesquita, M., Manso, A., Carapeta, S., Sobral, M., Figueiredo, A., Rodrigues, C., Milheiro, A., Carvalho, A., Perdigoto, R., Barroso, E., & Pereira-Leal, J. B. (2022). A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery. https://doi.org/10.1097/sla.0000000000005637
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.